Pharmaceutical Products Company Selects The CMM Group To Control VOC Emissions From Solvent Based Coatings

As part of an overall plan to increase production with the future addition of a second production line, a leading pharmaceutical company selected a Regenerative Thermal Oxidizer from The CMM Group, LLC to control the VOC emissions generated in the production of transdermal drug delivery technologies.

Equipped with ceramic monolith media, the 6,000 scfm RTO destroys up to 98% of the VOCs produced by the solvent based coatings that are part of the production process for various products and components.